BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27510535)

  • 1. Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children.
    Nandivada P; Baker MA; Mitchell PD; O'Loughlin AA; Potemkin AK; Anez-Bustillos L; Carlson SJ; Dao DT; Fell GL; Gura KM; Puder M
    Am J Clin Nutr; 2016 Sep; 104(3):663-70. PubMed ID: 27510535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.
    Wang C; Venick RS; Shew SB; Dunn JCY; Reyen L; Gou R; Calkins KL
    JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):708-716. PubMed ID: 30411372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of biochemical liver function with low-dose soy-based lipids in children with intestinal failure-associated liver disease.
    Khan FA; Fisher JG; Sparks EA; Potemkin A; Duggan C; Raphael BP; Modi BP; Jaksic T
    J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):375-7. PubMed ID: 25714580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil.
    Calkins KL; Dunn JC; Shew SB; Reyen L; Farmer DG; Devaskar SU; Venick RS
    JPEN J Parenter Enteral Nutr; 2014 Aug; 38(6):682-92. PubMed ID: 23894176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fish Oil Emulsion Reduces Liver Injury and Liver Transplantation in Children with Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Study.
    Gura KM; Premkumar MH; Calkins KL; Puder M
    J Pediatr; 2021 Mar; 230():46-54.e2. PubMed ID: 33038344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of hepatic fibrosis in pediatric intestinal failure patients treated with intravenous fish oil lipid emulsion.
    Belza C; Thompson R; Somers GR; de Silva N; Fitzgerald K; Steinberg K; Courtney-Martin G; Wales PW; Avitzur Y
    J Pediatr Surg; 2017 May; 52(5):795-801. PubMed ID: 28189450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Fish Oil and Pediatric Intestinal Failure-Associated Liver Disease: Changes in Plasma Phytosterols, Cytokines, and Bile Acids and Erythrocyte Fatty Acids.
    Calkins KL; DeBarber A; Steiner RD; Flores MJ; Grogan TR; Henning SM; Reyen L; Venick RS
    JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):633-641. PubMed ID: 28521607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy.
    Lee S; Park HJ; Yoon J; Hong SH; Oh CY; Lee SK; Seo JM
    JPEN J Parenter Enteral Nutr; 2016 Mar; 40(3):437-40. PubMed ID: 25560679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 122 Reflects Liver Injury in Children with Intestinal Failure-Associated Liver Disease Treated with Intravenous Fish Oil.
    Calkins KL; Thamotharan S; Ghosh S; Dai Y; Devaskar SU
    J Nutr; 2020 May; 150(5):1144-1150. PubMed ID: 32072161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy.
    Nandivada P; Chang MI; Potemkin AK; Carlson SJ; Cowan E; Oʼloughlin AA; Mitchell PD; Gura KM; Puder M
    Ann Surg; 2015 Jan; 261(1):172-9. PubMed ID: 24374535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
    Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
    Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
    Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of Smoflipid® and Intralipid® in the Early Management of Infants with Intestinal Failure.
    Casson C; Nguyen V; Nayak P; Channabasappa N; Berris K; Panczuk J; Bhiladvala C; Dasgupta T; Piper HG
    J Pediatr Surg; 2020 Jan; 55(1):153-157. PubMed ID: 31672409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Intravenous Soybean and Fish Oil Emulsions in Pediatric Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Analysis Report on Extrahepatic Adverse Events.
    Gura KM; Calkins KL; Premkumar MH; Puder M
    J Pediatr; 2022 Feb; 241():173-180.e1. PubMed ID: 34695449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic fibrosis persists and progresses despite biochemical improvement in children treated with intravenous fish oil emulsion.
    Mercer DF; Hobson BD; Fischer RT; Talmon GA; Perry DA; Gerhardt BK; Grant WJ; Botha JF; Langnas AN; Quiros-Tejeira RE
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):364-9. PubMed ID: 23201707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and development of cholestasis in surgical neonates receiving an intravenous mixed-oil lipid emulsion.
    Yu LJ; Anez-Bustillos L; Mitchell PD; Ko VH; Secor JD; Hurley AP; Dao DT; Fligor SC; Cho BS; Tsikis ST; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):30-40. PubMed ID: 36308408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children.
    Le HD; de Meijer VE; Robinson EM; Zurakowski D; Potemkin AK; Arsenault DA; Fallon EM; Malkan A; Bistrian BR; Gura KM; Puder M
    Am J Clin Nutr; 2011 Sep; 94(3):749-58. PubMed ID: 21775562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Lipid Emulsions in the Prevention and Treatment of Liver Disease in Intestinal Failure.
    Rochling FA
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fish oil-based lipid emulsions in the treatment of parenteral nutrition-associated liver disease: an ongoing positive experience.
    Premkumar MH; Carter BA; Hawthorne KM; King K; Abrams SA
    Adv Nutr; 2014 Jan; 5(1):65-70. PubMed ID: 24425724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.
    Puder M; Valim C; Meisel JA; Le HD; de Meijer VE; Robinson EM; Zhou J; Duggan C; Gura KM
    Ann Surg; 2009 Sep; 250(3):395-402. PubMed ID: 19661785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.